Stock Events

BriaCell Therapeutics 

C$4.48
3
-C$0.29-6.08% Monday 20:59

Statistics

Day High
4.91
Day Low
4.38
52W High
10.58
52W Low
4.14
Volume
4,260
Avg. Volume
5,024
Mkt Cap
76.23M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11MarExpected
Q1 2022
Q3 2022
Q3 2022
Q4 2022
Q3 2023
Q3 2023
Next
-1.02
-0.68
-0.34
0
Expected EPS
-0.2
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BCT.TO. It's not an investment recommendation.

About

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
Show more...
CEO
Dr. William V. Williams M.D.
Employees
16
Country
CA
ISIN
CA1079301091
WKN
000A2PXS5

Listings